While you see both these with respect to cancer screening, I wanted to know the difference between the two to compare between interventions and survival.
Consider two groups A and B.
Group A: Receives treatment with A and then is followed until death.
Group B: Receives treatment with A. After several weeks receives treatment with B. And then followed until death.
Note: This is not a prospective randomized trial.
Now, an early death prevents a patient from getting B. Patients who died
quickly had less time available to get transplants and will be counted as group A. Is this (Time A to B) causing an immortal time bias or lead time bias?